From: Altered monocyte activation markers in Tourette’s syndrome: a case–control study
TNF-alpha | IL1-ra | sCD14 | Neopterin | ||
---|---|---|---|---|---|
(pg/ml) | (ng/ml) | (ng/ml) | (nmol/l) | ||
Healthy | mean ± SD | 0.67 ± 0.24 | 0.056 ± 0.051 | 8.0 ± 1.4 | 4.70 ± 1.09 |
children vs. | rank sum | 24.00 | 29.45 | 18.89 | 18.80 |
healthy | mean ± SD | 0.51 ± 0.23 | 0.035 ± 0.058 | 8.6 ± 2.1 | 5.31 ± 1.90 |
adults | rank sum | 17.15 | 19.02 | 21.59 | 22.34 |
p-value* (n) | n.s. (10/27) | 0.017 (10/32) | n.s. (9/32) | n.s. (10/32) | |
TS children | mean ± SD | 0.46 ± 0.20 | 0.056 ± 0.136 | 6.3 ± 1.0 | 5.35 ± 1.79 |
vs. | rank sum | 22.50 | 25.07 | 20.37 | 17.54 |
TS adults | mean ± SD | 0.41 ± 0.18 | 0.014 ± 0.096 | 6.6 ± 1.6 | 6.32 ± 2.07 |
rank sum | 19.42 | 21.17 | 23.60 | 24.16 | |
p-value* (n) | n.s. (14/26) | n.s. (15/29) | n.s. (15/29) | n.s. (14/29) | |
Healthy | mean ± SD | 0.67 ± 0.24 | 0.056 ± 0.051 | 8.0 ± 1.4 | 4.70 ± 1.09 |
children vs. | rank sum | 16.00 | 17.05 | 17.72 | 11.25 |
TS children | mean ± SD | 0.46 ± 0.20 | 0.056 ± 0.136 | 6.3 ± 1.0 | 5.35 ± 1.79 |
rank sum | 10.00 | 10.30 | 9.37 | 13.39 | |
p-value* (n) | 0.042 (10/14) | 0.023 (10/15) | 0.003 (9/15) | n.s. (10/14) | |
Healthy adults | mean ± SD | 0.51 ± 0.23 | 0.035 ± 0.058 | 8.6 ± 2.1 | 5.31 ± 1.90 |
vs. | rank sum | 30.54 | 35.48 | 39.48 | 26.20 |
TS adults | mean ± SD | 0.41 ± 0.18 | 0.014 ± 0.096 | 6.6 ± 1.6 | 6.32 ± 2.07 |
rank sum | 23.33 | 26.05 | 21.64 | 36.29 | |
p-value* (n) | n.s. (27/26) | 0.038 (32/29) | 0.000 (32/29) | 0.027 (32/29) |